BioAge wants to raise $158 million through IPO
Ziarul Bursa,
BioAge Labs Inc. , an American clinical-stage biotech company developing therapies for obesity and metabolic diseases, is seeking to raise about $158 million through its initial public offering IPO) and a private placement, Bloomberg reports. continuă pe Ziarul Bursa